Ribon Therapeutics
Cancer drugs that target specific types of poly ADP-ribose polymerase
3
Funding Rounds
$190.2m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Au*** | - | - | - |
| Ey** Li******* | - | - | |
| Je** Go**** | - | - | - |
| Jo****** Ro** | - | - | - |
| em** re*** | - | - | |
| Pr***** Ra*** | - | - | - |
| La*** Br*** | - | - | - |
| Jo*** Mo****** | - | - | - |
| Ca***** Wh***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Ribon Therapeutics has raised a total of $130m in funding over 3 rounds.
Key Insights:
- Ribon Therapeutics , July 2021: $65m
- Ribon Therapeutics Series B round, January 2018: $65m
- Ribon Therapeutics, Inc. funding round, June 2021: $60.15m
Ribon Therapeutics , July 2021
$65m
Ribon Therapeutics Series B round, January 2018
$65m
Ribon Therapeutics, Inc. funding round, June 2021
$60.15m
Industries
Ribon Therapeutics is active in the following industries:
- Oncology
- Biology
- Biotechnology
- Healthcare
- Internal medicine
- Medicine
- Biomedical engineering
- Engineering
- Biopharmaceutical
- Technology
- Cancer